ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

February 2023, Vol 159, No. 2, Pages 134-227

Editorial

Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the ÌÇÐÄvlog

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):135-136. doi:10.1001/jamadermatol.2022.6161

A Tribute to Samuel Moschella

Abstract Full Text
JAMA Dermatol. 2023;159(2):136-138. doi:10.1001/jamadermatol.2022.5639
Original Investigation

Automating Hair Loss Labels for Universally Scoring Alopecia From Images: Rethinking Alopecia Scores

Abstract Full Text
free access has audio
JAMA Dermatol. 2023;159(2):143-150. doi:10.1001/jamadermatol.2022.5415

This research study develops and validates a new model, HairComb, to automatically compute the percentage of hair loss from images regardless of alopecia subtype.

Association of All-Cause and Cause-Specific Mortality Risks With Pyoderma Gangrenosum

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):151-159. doi:10.1001/jamadermatol.2022.5437

This cohort study examines all-cause and cause-specific mortality in patients with pyoderma gangrenosum.

Association of Patient Risk Factors, Tumor Characteristics, and Treatment Modality With Poor Outcomes in Primary Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):160-171. doi:10.1001/jamadermatol.2022.5508

This systematic review and meta-analysis of 129 studies evaluates the predictors and treatment outcomes for primary cutaneous squamous cell carcinoma among a total of 137 449 patients.

Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):172-181. doi:10.1001/jamadermatol.2022.5607

This cross-sectional study evaluates established comorbidities of excessive scarring in UK Biobank participants, with comparisons across ethnic groups, and identifies novel comorbidities via a phenome-wide association study.

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere)

Abstract Full Text
open access
JAMA Dermatol. 2023;159(2):182-191. doi:10.1001/jamadermatol.2022.5534

This randomized clinical trial examines the efficacy and safety of lebrikizumab in combination with background topical corticosteroid therapy in adolescents and adults with moderate-to-severe atopic dermatitis.

Brief Report

Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma

Abstract Full Text
JAMA Dermatol. 2023;159(2):192-197. doi:10.1001/jamadermatol.2022.5740

This cohort study characterizes the clinical characteristics, course of hospitalization, and mortality outcomes of an inpatient cohort with cutaneous T-cell lymphoma.

Characteristics Associated With Refractory Course, Blindness, and Treatment Strategy–Related Outcomes in Patients With Mucous Membrane Pemphigoid

Abstract Full Text
JAMA Dermatol. 2023;159(2):198-203. doi:10.1001/jamadermatol.2022.5829

This cohort study evaluates characteristics associated with refractory disease course and blindness among patients with mucous membrane pemphigoid and estimates the association of treatment strategies with prognostic outcome.

Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements

Abstract Full Text
JAMA Dermatol. 2023;159(2):204-208. doi:10.1001/jamadermatol.2022.5850

This cross-sectional study surveys patients with erythropoietic protoporphyria to describe the disease’s cutaneous symptoms and whether symptom severity is associated with degree of light sensitivity.

Images in Dermatology

Porokeratosis

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(2):209. doi:10.1001/jamadermatol.2022.5108

This case report describes multiple, hyperpigmented plaques involving the face, trunk, and bilateral upper and lower extremities.

Lamellar Ichthyosis

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(2):210. doi:10.1001/jamadermatol.2022.5112

This case report describes a patient in her 30s who was born with ichthyosis who presented with plate-like scale that covered her whole body as well as ectropion.

JAMA Dermatology Clinicopathological Challenge

Nonhealing Genital Ulcers as Clue to a Multisystem Disease

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(2):211-212. doi:10.1001/jamadermatol.2022.5863

A female patient in her late 40s presented with a 3-year history of nonhealing ulcers in her groin and axillae. What is your diagnosis?

Generalized, Linear Hyperkeratotic Papules With Numerous White Spicules and Comedo-like Plugs

Abstract Full Text
has active quiz
JAMA Dermatol. 2023;159(2):213-214. doi:10.1001/jamadermatol.2022.5773

A school-aged boy presents with generalized, linear hyperkeratotic papules with numerous central small filiform keratotic white spicules and brown plugs on the head, face, neck, trunk, and bilateral upper and lower extremities. What is your diagnosis?

Research Letter

Association Between Metastatic Melanoma Response to Checkpoint Inhibitor Therapy and Tumor-Infiltrating Lymphocyte Classification on Primary Cutaneous Melanoma Biopsies

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):215-216. doi:10.1001/jamadermatol.2022.4959

This cohort study examines the association between tumor-infiltrating lymphocyte classification and disease progression among patients with metastatic primary cutaneous melanoma receiving checkpoint inhibitor therapy.

Hidradenitis Suppurativa in Older Adults

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):216-219. doi:10.1001/jamadermatol.2022.5390

This cohort study describes the clinical characteristics of patients aged 65 years or older with hidradenitis suppurativa.

High-Dose Vitamin D for the Management of Toxic Erythema of Chemotherapy in Hospitalized Patients

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):219-222. doi:10.1001/jamadermatol.2022.5397

This case series describes the outcome of high-dose vitamin D treatment in 6 inpatients with acute skin injury.

Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):222-224. doi:10.1001/jamadermatol.2022.5710

This cohort study assesses whether an association exists between biologic treatment for hidradenitis suppurativa and neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and monocyte-lymphocyte ratio.

Observation

Treatment With Anifrolumab for Discoid Lupus Erythematosus

Abstract Full Text
JAMA Dermatol. 2023;159(2):224-226. doi:10.1001/jamadermatol.2022.5242

This case report describes 2 women with severe and refractory discoid lupus erythematosus that was treated with anifrolumab.

Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum

Abstract Full Text
JAMA Dermatol. 2023;159(2):226-227. doi:10.1001/jamadermatol.2022.5261

This case report describes treatment regimens with topical calcipotriol plus fluorouracil for 2 patients with xeroderma pigmentosum.

Correction

Clarification of Conflict of Interest Disclosures

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):227. doi:10.1001/jamadermatol.2022.5551

Error in Conflict of Interest Disclosures

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):227. doi:10.1001/jamadermatol.2022.6547
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2023;159(2):134. doi:10.1001/jamadermatol.2022.4400
×